The global hemostasis and
tissue sealing agents market is expected to reach USD 7.4 billion by 2022,
according to a new report by Grand View Research Inc. The global hemostasis and
tissue sealing agents market has gained popularity over time due to its ability
in preventing blood loss. Rapid growth of minimal invasive technology and
rising demand for faster recovery by patients is expected to promote market
growth over the forecast period.
According to the CDC,
approximately 150 million of American population is currently suffering with at
least one chronic condition, which leads to surgeries and even mortality at
times. An estimate over the rising incidence was made by the CDC, which
concluded that over 48% of the entire American population is expected to suffer
by chronic condition.
The demand for wound management
is expected to rise with increasing chronic disease incidence over the next
seven years. The Public Health Agency of Canada in its report stated that the
chronic disease occurrence rate is anticipated to increase by 14% annually and
four out of five cases are of high risk requiring immediate treatment and
surgeries.
In depth research report on Hemostasis And Tissue Sealing
Agents Market
Further key findings from the report suggest:
·
The hemostats market is
expected to grow at a CAGR of over9.0% over the forecast period owing to, the
rise in global volume of surgeries and increased applicability across a variety
of surgeries. The products avoid occurrence of hypovolemic shock,
thrombocytopenia, blood transfusions, and increase in post-operative
complications.
·
Flowable hemostats are a
combination of active and mechanical agents. They function by blocking blood
flow and also convert fibrinogen into fibrin for the coagulation process to
commence. This segment is expected to grow at a lucrative CAGR of over 10.0%
from 2015 to 2022.
·
North America is estimated to
be the largest market for the hemostasis and tissue sealing agents over the
forecast period and is expected to account for over 30.0% share by 2022.
·
Asia Pacific is identified as a
lucrative market due to a rapid growth in the surgery volume brought about by
the introduction of medical tourism. It is anticipated to account for over
27.0% of the overall market share by 2022. The Europe hemostasis and tissue
sealing agents market is expected to be driven by the rise in geriatric
population base, which is expected to ultimately lead to a surge in procedure
volume.
·
Some key players of this market
include Johnson & Johnson, CryoLife Inc, Pfizer, C R Bard, B Braun,
Covidien, and Smith & Nephew.
·
Market participants are
involved in technological advancements in order to ensure sustainability and
improve regional presence.
·
For instance, in March 2015,
Ethicon announced higher efficiency of EVARREST fibrin sealant patch as
compared to its substitute, TachoSil patch (Baxter). Further study would be
conducted at the St. Vincent Heart Centre of Indiana to understand added
advantages that the product can offer.
·
In August 2015, Integra Life
Sciences announced a new application of the Integra Dermal Regeneration
Template in chronic diabetes-based foot ulcers. The product is expected to be
used for treating these ulcers post its approval by the FDA in 2016.
Grand View Research has
segmented the global hemostasis and tissue sealing agents market on the basis
of product and region:
Hemostasis and Tissue Sealing Agents Product Outlook
(Revenue, USD Million, 2012 - 2022)
·
Topical hemostats
·
Active
·
Mechanical
·
Flowable
·
Tissue sealing Agents
·
Natural
·
Synthetic
·
Adhesion barrier products
Hemostasis and Tissue Sealing Agents Regional Outlook
(Revenue, USD Million, 2012 - 2022)
·
North America
·
U.S.
·
Canada
·
Europe
·
UK
·
Germany
·
France
·
Italy
·
Spain
·
Asia Pacific
·
Japan
·
China
·
India
·
Latin America
·
Brazil
·
MEA
·
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment